Abstract
AbstractInvestigating the gut microbiome and metabolome frequently requires faecal samples, which can be difficult to obtain. Previous studies have shown that rectal swabs are comparable to faecal samples for analysing gut microbiota composition and key metabolites. In this study, 3D printed rectal swabs were compared with conventional flocked swabs and faecal samples, due to the potential advantages 3D printing as a technique offers for swab production and development. 16S rRNA gene sequencing, qPCR and metabolite profiling (using 1H-NMR spectroscopy) were performed on swab and faecal samples from healthy participants. Faecal calprotectin and total protein analysis were performed on samples from inflammatory bowel disease (IBD) patients. There were no significant differences between both swab types and faecal samples when assessing key measures of alpha and beta diversity, and differences in the abundance of major phyla. There was a strong correlation between both swab types and faecal samples for all combined metabolites detected by NMR. In IBD patients, there was no significant difference in faecal calprotectin and total protein levels between both swab types and faecal samples. These data lead us to conclude that 3D printed swabs are equivalent to flocked swabs for the analysis of the gut microbiome, metabolome and inflammation.
Publisher
Springer Science and Business Media LLC
Reference23 articles.
1. Lecky, D. M., Hawking, M. K. & McNulty, C. A. Patients’ perspectives on providing a stool sample to their GP: A qualitative study. Br. J. Gen. Pract. 64, e684–e693 (2014).
2. Maréchal, C. et al. Compliance with the faecal calprotectin test in patients with inflammatory bowel disease. United Eur. Gastroenterol. J. 5, 702–707 (2017).
3. Williams, G. M. et al. Gut microbiome analysis by post: Evaluation of the optimal method to collect stool samples from infants within a national cohort study. PLoS ONE 14, e0216557 (2019).
4. Jalanka, J. et al. Effects of bowel cleansing on the intestinal microbiota. Gut 64, 1562–1568 (2015).
5. UK Health Security Agency. Actions to Contain Carbapenemase-Producing Enterobacterales (CPE). https://www.gov.uk/government/publications/actions-to-contain-carbapenemase-producingenterobacterales-cpe (2022).